Boehringer Mannheim Pharmaceuticals Corporation contributes cardiovascular products to healthcare centers overseas; improving quality of life worldwide is long-term goal.NEW WINDSOR New Windsor is the name of several places:
n. A class of diuretic agents that act by inhibiting reabsorption of sodium and chloride. loop diuretic Demadex(R) (torsemide). The 15,000 100-tablet bottles of Demadex(R) will be granted to I.M.A. for distribution to those in need overseas. "A primary goal of BMPC has always been to offer quality healthcare products and services," said Jon Rogers, M.D., Vice President, Medical and Scientific Affairs, at BMPC. "We are pleased to be part of an effort that brings together private industry and charitable organizations This article is about charitable organizations. For other uses of the word charity, see Charity. A charitable organization (also known as a charity) is an organization with charitable purposes only. to fill a healthcare void in places where it is needed most." Demadex(R) is a loop diuretic indicated for the treatment of edema edema (ĭdē`mə), abnormal accumulation of fluid in the body tissues or in the body cavities causing swelling or distention of the affected parts. associated with congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. , hypertension, hepatic hepatic /he·pat·ic/ (he-pat´ik) pertaining to the liver. he·pat·ic adj. 1. Of, relating to, or resembling the liver. 2. Acting on or occurring in the liver. n. disease and renal disease Renal disease Kidney disease. Mentioned in: Glycogen Storage Diseases hypertension High blood pressure Cardiovascular disease An abnormal ↑ systemic arterial pressure, corresponding to a systolic BP of > 160 mm Hg . Demadex(R) has been available in the U.S. market since 1993. "We are deeply moved by the generosity of Boehringer Mannheim," said Paul Derstine, I.M.A. Executive Director. "This major contribution represents the beginning of a partnership that will significantly extend I.M.A.'s resources in addressing the overwhelming healthcare needs of people around the world." Boehringer Mannheim Pharmaceuticals Corporation (BMPC) is headquartered in Gaithersburg, Maryland. As the U.S. affiliate of Boehringer Mannheim-Therapeutics, the global therapeutics division of Corange Limited, the Company works closely with the global diagnostics and orthopaedics divisions, Boehringer Mannheim-Diagnostics and DePuy Orthopaedics, in a joint effort to provide consumers with total health management solutions. By developing and providing innovative diagnostic, therapeutic and monitoring options, together, and in collaboration with their partners, the companies are working to reduce total healthcare expenditures worldwide. Interchurch Medical Assistance, Inc. is a Maryland-based non-profit association of 15 relief and development agencies who represent a vast constituency of churches in America and throughout the world. For 35 years, its mission has been to procure and distribute medicines and hospital supplies for overseas healthcare programs which serve people in need without regard to religion, ethnic background or political affiliation. In the last five years I.M.A. received, packed and shipped medical materials valued at $75 million dollars to over 120 countries. CONTACT: Interchurch Medical Assistance Inc. (I.M.A.) Kathleen Campanella, 410/635-8747 or BMPC Carol Peterson, 301/216-3722 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion